Kue-Hsiung Hsieh is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for allergic diseases. With a total of two patents to his name, Hsieh's work focuses on recombinant eukaryotic plasmids that aim to prevent and treat allergies.

Latest Patents

Hsieh's latest patents include "Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases." This invention relates to recombinant eukaryotic plasmids that comprise an eukaryotic expression vector and an allergen gene. The method involves administering the recombinant vector containing the allergen gene to individuals through intramuscular injection, intranasal delivery, or intratracheal delivery. This approach has been shown to inhibit the production of allergen-specific IgE synthesis. Additionally, the invention encompasses pharmaceutical compositions that utilize the recombinant vector for the prevention and treatment of allergic diseases.

Career Highlights

Throughout his career, Kue-Hsiung Hsieh has worked with various companies, including Jen Wen Co., Ltd. His expertise in biotechnology and innovative approaches to allergy treatment have positioned him as a key figure in his field.

Collaborations

Hsieh has collaborated with notable individuals such as Ching-Hsiang Hsu and Kaw-Yan Chua. These collaborations have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Kue-Hsiung Hsieh is a prominent inventor whose work in recombinant eukaryotic plasmids has the potential to revolutionize the treatment of allergic diseases. His innovative patents and collaborations highlight his commitment to improving health outcomes for individuals suffering from allergies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com